TPI Polene PCL (BKK:TPIPL)

Market Cap	17.23B
Revenue (ttm)	36.31B
Net Income (ttm)	1.42B
Shares Out	18.94B
EPS (ttm)	0.08
PE Ratio	12.10
Forward PE	n/a
Dividend	0.05 (5.49%)
Ex-Dividend Date	Mar 12, 2025

Volume	4,199,966
Average Volume	4,474,134
Open	0.9300
Previous Close	0.9200
Day's Range	0.9000 - 0.9400
52-Week Range	0.7200 - 1.2900
Beta	0.43
RSI	59.12
Earnings Date	Aug 8, 2025

About Regulus Therapeutics

TPI Polene Public Company Limited, together with its subsidiaries, manufactures and distributes cement products and mortar cement under the TPIPL brand in Thailand, China, Bangladesh, Australia, India, the Philippines, and internationally. It operates through Construction Materials, Petrochemical & Chemicals, Energy & Utilities, and Agriculture segments. The company offers cement products comprising masonry, plastering, and structural cement; mortar products, including masonry, plastering, floor screed, dry concrete, and other products; tile gr...

• Industry: Building Materials
• Sector: Materials
• Founded: 1987
• Employees: 6,113
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: TPIPL

Financial Performance

In 2024, TPI Polene PCL's revenue was 35.77 billion, a decrease of -16.44% compared to the previous year's 42.81 billion. Earnings were 1.44 billion, a decrease of -55.17%.